RPG Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

582.05

512.81

440.16

389.14

375.57

Operating profit

128.15

102.69

86.36

69.93

59.15

Interest

0.45

0.31

0.52

0.79

1.75

Gross profit

134.91

107.18

88.83

70.05

58.13

EPS (Rs)

53.01

40.90

31.13

24.19

17.54

Other income

7.21

4.80

2.99

0.91

0.73

Stock adjustment

2.70

-7.30

-25.21

-5.01

-5.98

Raw material

120.65

86.12

88.13

85.75

75.13

Power and fuel

-

-

-

-

-

Employee expenses

132.15

117.06

99.97

94.66

95.90

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

198.40

214.24

190.91

143.81

151.37

Provisions made

-

-

-

-

-

Depreciation

17.07

15.50

15.66

16.47

16.36

Taxation

30.18

24.04

21.69

13.58

7.44

Net profit / loss

87.66

67.64

51.48

40.00

29.01

Extra ordinary item

-

-

-

-

-5.32

Prior year adjustments

-

-

-

-

-

Equity capital

13.23

13.23

13.23

13.23

13.23

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

22.02

20.02

19.62

17.97

15.75

GPM (%)

22.89

20.71

20.05

17.96

15.45

NPM (%)

14.88

13.07

11.62

10.26

7.71